BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20038138)

  • 1. Mechanistic insight into cell growth, internalization, and cytotoxicity of PAMAM dendrimers.
    Parimi S; Barnes TJ; Callen DF; Prestidge CA
    Biomacromolecules; 2010 Feb; 11(2):382-9. PubMed ID: 20038138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells.
    Mukherjee SP; Lyng FM; Garcia A; Davoren M; Byrne HJ
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):259-68. PubMed ID: 20736030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimer internalization and intracellular trafficking in living cells.
    Albertazzi L; Serresi M; Albanese A; Beltram F
    Mol Pharm; 2010 Jun; 7(3):680-8. PubMed ID: 20394437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAMAM dendrimers with an oxyethylene unit-enriched surface as biocompatible temperature-sensitive dendrimers.
    Li X; Haba Y; Ochi K; Yuba E; Harada A; Kono K
    Bioconjug Chem; 2013 Feb; 24(2):282-90. PubMed ID: 23297782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-toxic phototriggered gene transfection by PAMAM-porphyrin conjugates.
    Shieh MJ; Peng CL; Lou PJ; Chiu CH; Tsai TY; Hsu CY; Yeh CY; Lai PS
    J Control Release; 2008 Aug; 129(3):200-6. PubMed ID: 18541326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAMAM dendrimer interactions with supported lipid bilayers: a kinetic and mechanistic investigation.
    Parimi S; Barnes TJ; Prestidge CA
    Langmuir; 2008 Dec; 24(23):13532-9. PubMed ID: 18980350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of PAMAM dendrimers to Chlamydomonas reinhardtii.
    Petit AN; Eullaffroy P; Debenest T; Gagné F
    Aquat Toxicol; 2010 Oct; 100(2):187-93. PubMed ID: 20206388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity.
    Shakhbazau A; Isayenka I; Kartel N; Goncharova N; Seviaryn I; Kosmacheva S; Potapnev M; Shcharbin D; Bryszewska M
    Int J Pharm; 2010 Jan; 383(1-2):228-35. PubMed ID: 19770028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress.
    Wang W; Xiong W; Wan J; Sun X; Xu H; Yang X
    Nanotechnology; 2009 Mar; 20(10):105103. PubMed ID: 19417510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between U-937 human macrophages and poly(propyleneimine) dendrimers.
    Kuo JH; Jan MS; Lin YL
    J Control Release; 2007 Jul; 120(1-2):51-9. PubMed ID: 17537537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the ability of PAMAM dendrimers and dendrimer/DNA aggregates to penetrate POPC model biomembranes.
    Ainalem ML; Campbell RA; Khalid S; Gillams RJ; Rennie AR; Nylander T
    J Phys Chem B; 2010 Jun; 114(21):7229-44. PubMed ID: 20455596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells.
    Naha PC; Davoren M; Lyng FM; Byrne HJ
    Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):91-9. PubMed ID: 20420846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization.
    Saovapakhiran A; D'Emanuele A; Attwood D; Penny J
    Bioconjug Chem; 2009 Apr; 20(4):693-701. PubMed ID: 19271737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
    Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
    Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the cytotoxity of poly(amidoamine) dendrimers by modification of a single layer of carboxybetaine.
    Wang L; Wang Z; Ma G; Lin W; Chen S
    Langmuir; 2013 Jul; 29(28):8914-21. PubMed ID: 23777276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.
    Zhang XQ; Intra J; Salem AK
    Bioconjug Chem; 2007; 18(6):2068-76. PubMed ID: 17848077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on polyamidoamine dendrimers as efficient gene delivery vector.
    Hui Zhong ; He ZG; Zheng Li ; Li GY; Shen SR; Li XL
    J Biomater Appl; 2008 May; 22(6):527-44. PubMed ID: 17623709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
    Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW
    Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
    Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
    Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines.
    Papagiannaros A; Dimas K; Papaioannou GT; Demetzos C
    Int J Pharm; 2005 Sep; 302(1-2):29-38. PubMed ID: 16099117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.